Relationships between the pharmaceutical industry and patients' organisations

Andrew Herxheimer, Herxheimer A
BMJ (Clinical research ed.) · 2003 · vol. 326(7400) , pp. 1208–10 · doi:10.1136/bmj.326.7400.1208 · PMID:12775627 · PMC1126060
Other OA: closed
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-15 ⓘ

The paper examines the relationships between the pharmaceutical industry and patients' organizations, though no abstract is available to specify findings related to endometriosis or adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Pharmaceutical companies and patients' organisations are unequal partners in a collaboration that has developed over the years—and this raises serious questions

My notes (saved in your browser only)

MeSH descriptors

Consumer Organizations Consumer Organizations Drug Industry Drug Industry Interprofessional Relations Financing, Organized Guidelines as Topic Humans Lobbying Self-Help Groups Self-Help Groups Trust

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-11-01T09:25:17.647243+00:00
pubmed
last seen: 2026-10-08T21:01:06.509505+00:00